DDD vs REGN · rev $440.1M vs P/E 14, rev $14.34B
3D Systems Corporation (DDD) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
3D Systems Corporation (DDD) is a computer hardware company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported DDD revenue for 2024-12-31 was $440.1M. Net income was -$255.6M. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. DDD currently screens at market cap $225.1M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
DDD currently screens at market cap $225.1M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the DDD and REGN stock pages for the full models.
Not investment advice.